A 2444 New Jersey General Assembly · 2024-2025 Regular Session

Requires DOH to study racial aspects of ovarian cancer.

This bill requires New Jersey's Department of Health (DOH) to study racial differences in ovarian cancer outcomes. The study must examine variations in cancer effects, rates, risk factors, symptoms, and treatment results among women of specific racial and ethnic groups, including Asian, African-American, Caucasian, Hispanic, Native American, and Pacific Islander communities. The DOH must complete the study and submit a report to the Governor and Legislature within one year of the bill's enactment, after which the bill expires. The measure directly affects women in these communities by seeking data to understand potential disparities in ovarian cancer care.
Bill status signed all 5 stages cleared
Introduction
Jan 2024
Committee Review
Dec 2024
General Assembly Passage
Mar 2024
Senate Passage
Dec 2025
Signed into Law
Jan 2026
Introduced Jan 9, 2024 Signed Jan 12, 2026
Floor votes · Senate Dec 18, 2025 · General Assembly Mar 18, 2024

How they voted

380
Passed · 2 other
Total votes 40
Dec 18, 2025
D Democratic25
24 Yea 1
96% Yea
R Republican15
14 Yea 1
93% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
8
Key actions
5
Committee
3
Jan 12, 2026
Signed into law
Approved P.L.2025, c.233.
executive
Dec 18, 2025
Upper · Passed
Passed Senate (Passed Both Houses) (38-0)
upper
Dec 9, 2024
Upper · Passed
Reported out of Senate Committee, 2nd Reading
upper
Apr 11, 2024
Committee
Received in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
Mar 18, 2024
Lower · Passed
Passed Assembly (77-0-0)
lower
Feb 22, 2024
Lower · Passed
Reported out of Assembly Committee with Amendments, 2nd Reading
lower
Jan 9, 2024
Introduced
Introduced in the Assembly, Referred to Assembly Health Committee
lower
5 primary · 9 co-sponsors

Sponsors